Virtus ETF Advisers LLC Unity Biotechnology, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$5.28 - $9.67 $227,092 - $415,906	-43,010 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.0 - $7.6 $31,365 - $47,674	-6,273 Reduced 12.73%	43,010 $249,000
Q4 2019 Feb 13, 2020	BUY	$5.99 - $8.38 $121,842 - $170,457	20,341 Added 70.28%	49,283 $355,000
Q3 2019 Nov 12, 2019	SELL	$5.62 - $9.63 $9,059 - $15,523	-1,612 Reduced 5.28%	28,942 $177,000
Q2 2019 Aug 13, 2019	BUY	$7.59 - $10.21 $106,419 - $143,154	14,021 Added 84.81%	30,554 $290,000
Q1 2019 May 14, 2019	SELL	$7.65 - $16.66 $18,773 - $40,883	-2,454 Reduced 12.92%	16,533 $134,000
Q4 2018 Feb 05, 2019	BUY	$10.76 - $17.25 $204,300 - $327,525	18,987 New	18,987 $309,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $15M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.